Viewing Study NCT05369832


Ignite Creation Date: 2025-12-24 @ 9:37 PM
Ignite Modification Date: 2025-12-30 @ 9:03 PM
Study NCT ID: NCT05369832
Status: TERMINATED
Last Update Posted: 2025-05-20
First Post: 2022-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module